<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Protein Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id>
<journal-title-group>
<journal-title>Protein &amp; Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1674-800X</issn>
<issn pub-type="epub">1674-8018</issn>
<publisher>
<publisher-name>Higher Education Press</publisher-name>
<publisher-loc>Beijing</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29725935</article-id>
<article-id pub-id-type="pmc">5960473</article-id>
<article-id pub-id-type="publisher-id">549</article-id>
<article-id pub-id-type="doi">10.1007/s13238-018-0549-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut microbiota derived metabolites in cardiovascular health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Zeneng</given-names>
</name>
<address>
<phone>216 445 2484</phone>
<email>wangz2@ccf.org</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yongzhong</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0675 4725</institution-id><institution-id institution-id-type="GRID">grid.239578.2</institution-id><institution>Department of Cellular and Molecular Medicine, Lerner Research Institute, </institution><institution>Cleveland Clinic, </institution></institution-wrap>Cleveland, OH 44195 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>3</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>416</fpage>
<lpage>431</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>4</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Trillions of microbes inhabit the human gut, not only providing nutrients and energy to the host from the ingested food, but also producing metabolic bioactive signaling molecules to maintain health and elicit disease, such as cardiovascular disease (CVD). CVD is the leading cause of mortality worldwide. In this review, we presented gut microbiota derived metabolites involved in cardiovascular health and disease, including trimethylamine-<italic>N</italic>-oxide (TMAO), uremic toxins, short chain fatty acids (SCFAs), phytoestrogens, anthocyanins, bile acids and lipopolysaccharide. These gut microbiota derived metabolites play critical roles in maintaining a healthy cardiovascular function, and if dysregulated, potentially causally linked to CVD. A better understanding of the function and dynamics of gut microbiota derived metabolites holds great promise toward mechanistic predicative CVD biomarker discoveries and precise interventions.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s13238-018-0549-0) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>gut microbiota</kwd>
<kwd>metabolites</kwd>
<kwd>cardiovascular health</kwd>
<kwd>cardiovascular disease</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© HEP and Springer-Verlag GmbH Germany, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>INTRODUCTION</title>
<p id="Par2">There is a big gap in interpreting the molecular physiology by using the human genome coding capacity encompassing 23,000 coding genes (Gonzaga-Jauregui et al., <xref ref-type="bibr" rid="CR51">2012</xref>). The human gut is inhabited with 100 trillion microbes, with the majority as bacteria and archaea, fungi and microeukaryotes (Wampach et al., <xref ref-type="bibr" rid="CR164">2017</xref>). Almost 10 million coding genes of the microbiota have been uncovered, greatly expanding the coding capacity of our human as a superorganism (Qin et al., <xref ref-type="bibr" rid="CR127">2010</xref>; Li et al., <xref ref-type="bibr" rid="CR92">2014</xref>). Gut microbiota are essential to human health in many aspects, such as training intestinal epithelial barrier, modulating immuno-function, digesting host indigestible nutrients, producing vitamins and hormones and preventing pathogenic bacterium colonization (Schuijt et al., <xref ref-type="bibr" rid="CR136">2016</xref>). For a healthy subject, gut microbiota homeostasis is maintained with pathogenic microbe growth under control. Once the balance breaks, i.e., dysbiosis, pathogenic microbes thrive, leading to gut related diseases, such as inflammatory bowel disease (IBD), obesity, allergic disorders, diabetes mellitus, autism, colorectal cancer and cardiovascular disease (DeGruttola et al., <xref ref-type="bibr" rid="CR33">2016</xref>; Yang et al., <xref ref-type="bibr" rid="CR177">2015</xref>; Battson et al., <xref ref-type="bibr" rid="CR12">2017</xref>). Fecal microbiota transplantation has shown great efficacy in managing <italic>Clostridium difficile</italic> infection and Crohn’s disease (Bakken et al., <xref ref-type="bibr" rid="CR10">2013</xref>; Paasche <xref ref-type="bibr" rid="CR118">2013</xref>; Zhang et al., <xref ref-type="bibr" rid="CR183">2013</xref>). In animal model, fecal microbiota transplant to germ free mice recipients has been shown to transmit obesity and atherosclerosis susceptibility, suggesting the great potential of fecal microbiota transplantation in treating a panel of complex disease (Gregory et al., <xref ref-type="bibr" rid="CR53">2015</xref>; Turnbaugh et al., <xref ref-type="bibr" rid="CR155">2006</xref>). In addition, the prebiotic and probiotic administrations also show beneficial effects in optimizing gut microbiota community structure and preventing dysbiosis (Hamilton et al., <xref ref-type="bibr" rid="CR56">2017</xref>; Anhe et al., <xref ref-type="bibr" rid="CR5">2015</xref>; Delgado et al., <xref ref-type="bibr" rid="CR34">2014</xref>; Kouchaki et al., <xref ref-type="bibr" rid="CR84">2017</xref>).</p>
<p id="Par3">The association between gut microbiota and health has become a hot topic, the rapid progress in this field is ascribed to next generation sequencing methods as well as the ease of maintaining germ free mice (Mardis, <xref ref-type="bibr" rid="CR101">2008</xref>; Bhattarai and Kashyap, <xref ref-type="bibr" rid="CR15">2016</xref>).</p>
<p id="Par4">Gut microbes are involved in the biosynthesis of an array of bioactive compounds, contributing to normal human physiological functions or eliciting disease (Fan et al., <xref ref-type="bibr" rid="CR41">2015</xref>; Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>). CVD is the leading cause of death worldwide, the association with gut microbiota has been reported in recent few years, which is mediated by gut microbiota derived metabolites (Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>; Tang et al., <xref ref-type="bibr" rid="CR146">2013</xref>; Koeth et al., <xref ref-type="bibr" rid="CR82">2013</xref>). In this review, we listed gut microbiota derived metabolites and their clinical relevance in cardiovascular health and disease pathogenesis.</p>
</sec>
<sec id="Sec2">
<title>TRIMETHYLAMINE <italic>N</italic> OXIDE (TMAO)</title>
<p id="Par5">Gut microbiota cleave some trimethylamine containing compounds to produce trimethylamine (TMA), which can be further oxidized as trimethylamine N oxide (TMAO) in the host liver by flavin monooxygenase (FMOs) (Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>; Koeth et al., <xref ref-type="bibr" rid="CR82">2013</xref>). FMO3 is the most abundant enzyme in the liver, while FMO1 and FMO2 can also catalyze the oxidation of TMA (Bennett et al., <xref ref-type="bibr" rid="CR13">2013</xref>). In some patients with loss-of-function mutation of the FMO3 gene, accumulated TMA in vivo spreads all over the body and is released in sweat and breath, which is a genetic disease named fish odor syndrome (Dolphin et al., <xref ref-type="bibr" rid="CR38">1997</xref>; Ulman et al., <xref ref-type="bibr" rid="CR156">2014</xref>). The precursors for gut microbiota to produce TMA include TMAO, choline, phosphatidylcholine, carnitine, γ-butyrobetaine, betaine, crotonobetaine and glycerophosphocholine, all of which are abundant in animal diet (Koeth et al., <xref ref-type="bibr" rid="CR82">2013</xref>; Wang et al., <xref ref-type="bibr" rid="CR170">2015</xref>; Rausch et al., <xref ref-type="bibr" rid="CR131">2013</xref>).</p>
<p id="Par6">The diet-gut microbiota-liver to TMAO biosynthesis constitutes a metaorganismal pathway (Fig. <xref ref-type="fig" rid="Fig1">1</xref>), including four enzymes involved in production of TMA, choline-TMA lyase (cutC/D) (Craciun et al., <xref ref-type="bibr" rid="CR28">2014</xref>), carnitine monooxygenase (cntA/B) (Zhu et al., <xref ref-type="bibr" rid="CR188">2014</xref>), betaine reductase (Andreesen, <xref ref-type="bibr" rid="CR4">1994</xref>), and TMAO reductase (Pascal et al., <xref ref-type="bibr" rid="CR120">1984</xref>). Furthermore, yeaW/X, highly homologous to cntA/B, also contributes to production of TMA. Besides carnitine, yeaW/X can also use choline, γ-butyrobetaine and betaine as substrates to produce TMA (Koeth et al., <xref ref-type="bibr" rid="CR83">2014</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Metaorganismal pathway of trimethylamine N oxide (TMAO) biosynthesis and linking to cardiovascular disease</bold>. FMOs, Flavin monooxygenases. R1, R2, CH<sub>3</sub>(CH<sub>2</sub>)n<sub>1</sub>(CH=CH)n<sub>2</sub>, n<sub>2</sub> = 0, 1, 2…..6, n<sub>1</sub> + 2n<sub>2</sub>  = 15, 17, 19, 21</p></caption><graphic id="MO1" xlink:href="13238_2018_549_Fig1_HTML"></graphic></fig>
</p>
<p id="Par7">CutC/D has been crystalized and the enzymatic mechanism has been demonstrated. CutD, as a radical <italic>S</italic>-adenosylmethionine-activatase, activates CutC, resulting in formation of a glycyl radical. In CutC, the glycyl radical abstracts the hydrogen from cysteine to produce a thiyl radical and further captures the hydrogen atom from choline at C1 position, resulting in molecular rearrangement and TMA production. (Craciun et al., <xref ref-type="bibr" rid="CR28">2014</xref>; Kalnins et al., <xref ref-type="bibr" rid="CR77">2015</xref>; Bodea et al., <xref ref-type="bibr" rid="CR16">2016</xref>). CntA/B is a two-component Rieske-type oxygenase/reductase, carnitine can be first oxidized followed by cleavage at C-N bond by CntA/B to produce TMA and malic semialdehyde (Zhu et al., <xref ref-type="bibr" rid="CR188">2014</xref>). Hundreds of bacterial strains are predicted to express cutC/D or cntA/B-yeaW/X in the human gut (Fig. <xref ref-type="fig" rid="Fig2">2</xref>A, <xref ref-type="fig" rid="Fig2">2</xref>B, <xref ref-type="fig" rid="Fig2">2</xref>C and Table S1) (Rath et al., <xref ref-type="bibr" rid="CR130">2017</xref>; Martinez-del Campo et al., <xref ref-type="bibr" rid="CR102">2015</xref>). <italic>Proteus mirabilis</italic> is a cutC/D expressing bacterium species and since it can grow under both aerobic and anaerobic conditions, it has been used as a model to screen choline trimethylamine lyase inhibitors (Wang et al., <xref ref-type="bibr" rid="CR170">2015</xref>). It is most likely the gene tree of cutC substantially differs from species tree, e.g., species of the same genus but with distinct topology for <italic>Klebsiella</italic> (Fig. <xref ref-type="fig" rid="Fig2">2</xref>D). FMO3 expression in mice is regulated by sex hormone, repressed by androgens and stimulated by estrogens (Bennett et al., <xref ref-type="bibr" rid="CR13">2013</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p><bold>Predicted bacteria strains encoding the cutC/yeaW/cntA TMA lyases</bold>. (A) Predicted bacteria strains encoding cutC gene. Abbreviation, HMP, the NIH Human Microbiome Project (Data release 1.1, September 26, 2017 e), Ortho, cutC encoding gene of OrthoDB (<ext-link ext-link-type="uri" xlink:href="http://www.orthodb.org/v9.1/">http://www.orthodb.org/v9.1/</ext-link>) (Zdobnov et al., <xref ref-type="bibr" rid="CR181">2017</xref>), and VM, data from the reference (Rath et al., <xref ref-type="bibr" rid="CR130">2017</xref>). (B) Predicted bacteria stains encoding yeaW/cntA genes. Ortho, yeaW encoding gene of OrthoDB. (C) Predicted bacterial strains encoding both yeaW and cutC. (D) Phylogenetic gene tree of cutC encoding strains. The Neighbor-Joining tree was built with MEGA7 (Kumar et al., <xref ref-type="bibr" rid="CR85">2016</xref>)</p></caption><graphic id="MO2" xlink:href="13238_2018_549_Fig2_HTML"></graphic></fig>
</p>
<p id="Par8">Many lines of evidence show the pro-atherogenic property of TMAO. Circulating TMAO level is associated with prevalence of cardiovascular disease and can independently predict incident risk for major adverse cardiac events, including myocardial infarction, stroke or death after adjustment for traditional cardiac risk factors and renal function (Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>; Tang et al., <xref ref-type="bibr" rid="CR146">2013</xref>). Circulating choline, betaine and carnitine levels also have been shown associated with prevalence of cardiovascular disease and can predict incident risk for major adverse cardiac events. However, their prognostic values are dependent on the serum TMAO levels (Koeth et al., <xref ref-type="bibr" rid="CR82">2013</xref>; Wang et al., <xref ref-type="bibr" rid="CR169">2014</xref>). ApoE-null mice fed a chow diet supplemented with TMAO appear to have an enhanced aortic lesion. Furthermore, choline can also increase aortic lesion and promote atherosclerosis but indispensable to gut microbiota, indicating the causal of TMAO in atherosclerosis (Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>). In vitro animal models have also confirmed the prothrombotic effect of TMAO by enhancing platelet aggregation (Zhu et al., <xref ref-type="bibr" rid="CR189">2016</xref>). Consistently, oral choline supplementation increases fasting TMAO levels and also enhances platelet aggregation (Zhu et al., <xref ref-type="bibr" rid="CR190">2017</xref>).</p>
<p id="Par9">Mechanisms by which how TMAO can promote atherosclerosis and thrombosis have been studied at the molecular level. TMAO activates vascular smooth muscle cell and endothelial cell MAPK, nuclear factor-κB (NF-κB) signaling, leading to inflammatory gene expression and endothelial cell adhesion of leukocytes (Seldin et al., <xref ref-type="bibr" rid="CR138">2016</xref>). Meanwhile, TMAO can also activate the NLRP3 inflammasome (Sun et al., <xref ref-type="bibr" rid="CR143">2016</xref>; Boini et al., <xref ref-type="bibr" rid="CR18">2017</xref>; Chen et al., <xref ref-type="bibr" rid="CR22">2017</xref>). TMAO in vivo can increase scavenger receptor, CD36 and SR-A1 expression, leading to more uptake of modified LDL for macrophage to form foam cell (Wang et al., <xref ref-type="bibr" rid="CR166">2011</xref>). On the other hand, TMAO decreases expression of two key enzymes, CYP7A1 and CYP27A1, essential for bile acid biosynthesis and multiple bile acid transporters (OATP1, OATP4, MRP2 and NTCP) in the liver, which decreases bile acid pool, resulting in decreased reverse cholesterol efflux (Koeth et al., <xref ref-type="bibr" rid="CR82">2013</xref>). Moreover, TMAO increases endoplasmic recticulum calcium release in platelet cell, consequently leading to platelet aggregation and thrombosis (Zhu et al., <xref ref-type="bibr" rid="CR189">2016</xref>).</p>
<p id="Par10">The association between TMAO and cardiovascular disease has been highlighted in different groups by using different cohorts worldwide (Troseid et al., <xref ref-type="bibr" rid="CR151">2015</xref>; Suzuki et al., <xref ref-type="bibr" rid="CR144">2016</xref>, <xref ref-type="bibr" rid="CR145">2017</xref>; Schuett et al., <xref ref-type="bibr" rid="CR135">2017</xref>). Besides cardiovascular disease, TMAO also contributes to renal insufficiency and mortality risk in chronic kidney disease, type II diabetes, insulin resistance, non-alcoholic fatty liver disease and colorectal cancer as well (Tang et al., <xref ref-type="bibr" rid="CR147">2015</xref>; Shan et al., <xref ref-type="bibr" rid="CR139">2017</xref>; Oellgaard et al., <xref ref-type="bibr" rid="CR117">2017</xref>; Kummen et al., <xref ref-type="bibr" rid="CR86">2017</xref>). These studies indicate circulating TMAO levels has the potential to be managed for TMAO related diseases intervention. Specially, targeting the metaorganismal pathway for TMAO biosynthesis can be achieved by a few key steps, including inhibiting gut microbiota cleavage of TMA containing compounds in nutrient via enzymatic inhibitor, controlling intake of diet rich in TMA precursors and inhibiting the oxidation of TMA to TMAO.</p>
<p id="Par11">As expected, the injection of antisense oligonucleotide to <italic>Ldlr</italic>-null mice decreases the hepatic <italic>Fmo3</italic> gene expression, resulting in decreased mouse plasma TMAO thereby decreasing aortic lesion in western diet fed mice (Shih et al., <xref ref-type="bibr" rid="CR141">2015</xref>). However, the accumulated TMA in mice will show fish odor syndrome. In addition, <italic>Fmo3</italic> knockdown exacerbates hepatic endoplasmic reticulum (ER) stress and inflammation (Warrier et al., <xref ref-type="bibr" rid="CR174">2015</xref>). Thus, developing gut microbiota enzymatic inhibitors to inhibit TMA formation will be more practical.</p>
<p id="Par12">A choline analogue, 3,3-dimethylbutanol (DMB), has been uncovered with inhibitory effect to choline TMA lyase activity in turn decreasing circulating TMAO, and therefore attenuating the promoting role of choline in atherosclerosis (Wang et al., <xref ref-type="bibr" rid="CR170">2015</xref>). DMB is a natural product, distributed in certain balsamic vinegars, red wines, cold-pressed extra virgin olive oils and grapeseed oils. DMB has not been found any adverse effect to the liver or renal functions even as high as in mice drinking water up to 1% (Wang et al., <xref ref-type="bibr" rid="CR170">2015</xref>). Very recently, we have found that several more choline analogues show more potent in inhibiting choline TMA lyase activity than DMB (to be published). But inhibitors to different enzymatic cleavage of other substrates are still needed. Furthermore, a study shows that resveratrol, a phytoalexin, can decrease plasma TMAO and subsequent atherosclerosis in ApoE<sup>−/−</sup> mice via gut microbiota remodeling, characterized by increased levels of the genera <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> with increased bile salt hydrolase activity to increase bile acid neosynthesis, suggesting the potential of resveratrol as prebiotics (Chen et al., <xref ref-type="bibr" rid="CR21">2016</xref>).</p>
</sec>
<sec id="Sec3">
<title>UREMIC TOXINS</title>
<p id="Par13">Toxins, such as urea and asymmetric dimethylarginine, can be accumulated in blood during chronic kidney disease (CKD), associated to CKD complications especially heart failure which is the leading cause of CKD mortality (Glassock <xref ref-type="bibr" rid="CR50">2008</xref>). Moreover, protein-bound uremic toxins such as indoxyl sulfate, indoxyl glucuronide, indoleacetic acid, <italic>p</italic>-cresyl sulfate, <italic>p</italic>-cresyl glucuronide, phenyl sulfate, phenyl glucuronide, phenylacetic acid and hippuric acid have been reported to be increased in serum in hemodialysis patients (Itoh et al., <xref ref-type="bibr" rid="CR74">2013</xref>). These uremic toxins are gut microbiota derived metabolites of amino acids (Devlin et al., <xref ref-type="bibr" rid="CR37">2016</xref>). The aromatic amino acids in proteins, phenylalanine, tyrosine and tryptophan, can be metabolized by gut microbiota (Nallu et al., <xref ref-type="bibr" rid="CR114">2017</xref>; Pereira-Fantini et al., <xref ref-type="bibr" rid="CR121">2017</xref>). Both microbiota and host liver are involved in biosynthesis of these uremic toxins (Fig. <xref ref-type="fig" rid="Fig3">3</xref>) (Devlin et al., <xref ref-type="bibr" rid="CR37">2016</xref>; Meyer and Hostetter <xref ref-type="bibr" rid="CR107">2012</xref>; Webster et al., <xref ref-type="bibr" rid="CR175">1976</xref>; Gryp et al., <xref ref-type="bibr" rid="CR54">2005</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Gut microbiota involved in the biosynthesis of phenylacetic acid, p-cresyl sulfate and indoxyl sulfate</bold>
</p></caption><graphic id="MO3" xlink:href="13238_2018_549_Fig3_HTML"></graphic></fig>
</p>
<p id="Par14">The serum indoxyl sulfate level, positively correlated with coronary atherosclerosis scores, might be a predicative mechanistic biomarker of coronary artery disease severity (Hsu et al., <xref ref-type="bibr" rid="CR69">2013</xref>). Further studies have shown that indoxyl sulfate aggravates cardiac fibrosis, cardiomyocyte hypertrophy and atrial fibrillation (Yisireyili et al., <xref ref-type="bibr" rid="CR179">2013</xref>; Aoki et al., <xref ref-type="bibr" rid="CR6">2015</xref>). Atrial fibrillation, the most common clinical arrhythmia, results in cardiovascular morbidity and mortality attributed to congestive heart failure and stroke (Hung et al., <xref ref-type="bibr" rid="CR72">2017</xref>). Mechanistically, indoxyl sulfate enhances platelet activities, increases response to collagen and thrombin, leading to thrombosis (Yang et al., <xref ref-type="bibr" rid="CR178">2017</xref>). Vascular smooth muscle cell calcification is associated with major adverse cardiovascular events while indoxyl sulfate has been found to promote vascular smooth muscle cell calcification (Zhang et al., <xref ref-type="bibr" rid="CR185">2018</xref>). Indoxyl sulfate activates NF-κB signaling pathway, leading to increased intercellular adhesion molecule-1 (ICAM-1) and monocyte chemotactic protein-1 (MCP-1) expression in endothelial cells (Tumur et al., <xref ref-type="bibr" rid="CR154">2010</xref>). ICAMs over-expression in endothelial cells is the initiating step for atherosclerotic plaque formation (Moss and Ramji <xref ref-type="bibr" rid="CR113">2016</xref>). Indoxyl sulfate inhibits nitric oxide production and induces reactive oxygen species production, gradually damaging endothelial cell layer (Tumur and Niwa <xref ref-type="bibr" rid="CR153">2009</xref>). Taken together, these studies indicate indoxyl sulfate mechanistically linked to CVD at the molecular and cellular levels.</p>
<p id="Par15"><italic>p</italic>-Cresyl sulfate is a biomarker in predicting cardiovascular event and renal function progression in CKD patients without dialysis (Lin et al., <xref ref-type="bibr" rid="CR94">2014</xref>; Wu et al., <xref ref-type="bibr" rid="CR176">2012</xref>). <italic>p</italic>-Cresyl sulfate can induce NADPH oxidase activity to produce reactive oxygen species, resulting in cardiomyocyte apoptosis and subsequent diastolic dysfunction (Han et al., <xref ref-type="bibr" rid="CR57">2015</xref>). Apocynin and N-acetylcysteine, inhibitors to NADPH oxidase, can attenuate the effect of p-cresyl sulfate induced apoptosis (Han et al., <xref ref-type="bibr" rid="CR57">2015</xref>). <italic>p</italic>-Cresyl sulfate increased endothelial cell tumor necrosis factor-α (TNF-α), MCP-1, ICAM and VCAM expression, therefore mechanistically promotes atherogenesis (Jing et al., <xref ref-type="bibr" rid="CR75">2016</xref>). Given that p-cresyl sulfate, very similar to indoxyl sulfate, is notoriously difficult to eliminate by dialysis (Gryp et al., <xref ref-type="bibr" rid="CR54">2005</xref>), it is most likely that intervening the biosynthesis pathway is the best way to attenuate such toxic effect.</p>
</sec>
<sec id="Sec4">
<title>SHORT CHAIN FATTY ACIDS</title>
<p id="Par16">Short chain fatty acids (SCFAs) refer to fatty acids with a carbon number of not greater than 6, including three major SCFAs, acetic acid, propionic acid, butyric acid, and two less abundant valeric acid and caproic acid. Acetic acid, the most abundant SCFA in the colon with more than half of the total SCFA detected in feces, can be generated by carbohydrate fermentation, or synthesized from hydrogen and carbon dioxide or formic acid through the Wood-Ljungdahl pathway (Miller and Wolin, <xref ref-type="bibr" rid="CR109">1996</xref>; Louis et al., <xref ref-type="bibr" rid="CR97">2014</xref>). Three distinct pathways including succinate pathway, acrylate pathway, and propanodiol pathway, can generate propionic acid (Reichardt et al., <xref ref-type="bibr" rid="CR133">2014</xref>). Butyric acid-producing bacteria use two different pathways, the pathway using phosphotransbutyrylase and butyrate kinase enzymes to convert butyryl-CoA into butyrate (e.g., Coprococcus species) (Louis et al., <xref ref-type="bibr" rid="CR95">2004</xref>; Flint et al., <xref ref-type="bibr" rid="CR44">2015</xref>), and the butyryl-CoA/acetate CoA-transferase pathway, in which butyryl-CoA is converted to butyric acid in a single step enzymatic reaction (e.g., Faecalibacterium, Eubacterium and Roseburia) (Louis et al., <xref ref-type="bibr" rid="CR96">2010</xref>).</p>
<p id="Par17">The proposed biosynthesis of SCFAs in bacteria is sequential from glycolysis of glucose to pyruvate, to acetyl-coA, and eventually to acetic acid, propionic acid and butyric acid. Intriguingly, amino acids are alternative substrate for SCFAs biosynthesis. Glucose and amino acids can be digested from starch and protein in small intestine, respectively. Glucose and amino acids can be absorbed into circulating system rapidly prior to reaching colon where microbes accumulated, and the main substrate for the microbes to produce SCFAs is dietary fiber. Both inulin, a kind of fructan, found in many plants, and guar gum are prebiotic fiber (den Besten et al., <xref ref-type="bibr" rid="CR36">2015</xref>, <xref ref-type="bibr" rid="CR35">2014</xref>; Boets et al., <xref ref-type="bibr" rid="CR17">2015</xref>). The beneficial effect of inulin include increasing calcium absorption in colon and decreasing food intake thereafter loss-of-weight (Abrams et al., <xref ref-type="bibr" rid="CR1">2007</xref>; Harrold et al., <xref ref-type="bibr" rid="CR59">2013</xref>; Liber and Szajewska <xref ref-type="bibr" rid="CR93">2013</xref>). Many clinical trials have confirmed a lot of benefits of inulin on health promoting functions and reducing the risk of many diseases, leading to inulin extensively used as nutrient supplement (Kaur and Gupta <xref ref-type="bibr" rid="CR81">2002</xref>). Germ free animals have trace amounts of SCFAs, possibly from diet (Hoverstad et al., <xref ref-type="bibr" rid="CR68">1985</xref>; Hoverstad and Midtvedt <xref ref-type="bibr" rid="CR67">1986</xref>).</p>
<p id="Par18">Acetic acid producing bacteria are included in Acetobacteraceae containing 10 genera which can oxidize sugars or ethanol to produce acetic acid during fermentation (Raspor and Goranovic <xref ref-type="bibr" rid="CR129">2008</xref>). At least 33 strains can produce propionic acid and 225 strains can produce butyric acid by fermenting dietary fiber in human gut (Reichardt et al., <xref ref-type="bibr" rid="CR133">2014</xref>; Vital et al., <xref ref-type="bibr" rid="CR161">2014</xref>). More interestingly, dietary fiber can selectively increase SCFAs producing bacterium abundance (Zhao et al., <xref ref-type="bibr" rid="CR187">2018</xref>).</p>
<p id="Par19">Short chain fatty acids play important roles in human health. SCFAs can be used to feed colonocyte, maintain gut barrier and inhibit pathogenic microbe proliferation due to acidic pH condition (Hashemi et al., <xref ref-type="bibr" rid="CR60">2017</xref>; Cherrington et al., <xref ref-type="bibr" rid="CR24">1991</xref>; Prohaszka et al., <xref ref-type="bibr" rid="CR126">1990</xref>; Duncan et al., <xref ref-type="bibr" rid="CR40">2009</xref>; Manrique Vergara and Gonzalez Sanchez, <xref ref-type="bibr" rid="CR100">2017</xref>). SCFAs can work as inhibitors to histone deacetylase (HDAC), which decreases expression of the miR-106b family and increases p21 expression, leading to human colon cancer cell apoptosis (Chen et al., <xref ref-type="bibr" rid="CR20">2003</xref>; Hu et al., <xref ref-type="bibr" rid="CR70">2011</xref>; Heerdt et al., <xref ref-type="bibr" rid="CR62">1997</xref>). SCFAs functions as anticancer therapeutics (Chen et al., <xref ref-type="bibr" rid="CR20">2003</xref>). There are three SCFAs receptors expressed in colon epithelial cells including GPR43 (FFAR2), GPR41 (FFAR3) and GPR109A (Karaki et al., <xref ref-type="bibr" rid="CR79">2008</xref>; Tazoe et al., <xref ref-type="bibr" rid="CR148">2009</xref>; Ahmed et al., <xref ref-type="bibr" rid="CR2">2009</xref>). These receptor can trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 to influence metabolic state and increase peripheral glucose clearance (den Besten et al., <xref ref-type="bibr" rid="CR36">2015</xref>; Tolhurst et al., <xref ref-type="bibr" rid="CR149">2012</xref>). GPR109A can only be activated by butyric acid, not by acetic acid or propionic acid (Ahmed et al., <xref ref-type="bibr" rid="CR2">2009</xref>). Meanwhile, there is another SCFA receptor, OLFR78, expressed in blood vessel and activated by acetic acid and propionic acid but not by butyric acid involved in the modulation of the blood pressure (Pluznick et al., <xref ref-type="bibr" rid="CR124">2013</xref>; Pluznick <xref ref-type="bibr" rid="CR123">2014</xref>). In addition, recent studies have found a panel of SCFA receptors expressed in distinct cell types, e.g., FFAR2 and FFAR3 in pancreatic β-cells, FFA3 in neurons, FFA2 in leukocytes, as well as FFA2 and GPR109A in adipocytes, indicating that the ubiquitous and cell-type specific functions of SCFAs (Ahmed et al., <xref ref-type="bibr" rid="CR2">2009</xref>; Nilsson et al., <xref ref-type="bibr" rid="CR116">2003</xref>). Thus, gut microbiota derived SCFAs actively participate in the host energy hemostasis regulation, play critical regulatory functions in brain, muscle, airway, white adipose tissue, brown adipose tissue and blood vessel physiology (Kasubuchi et al., <xref ref-type="bibr" rid="CR80">2015</xref>).</p>
<p id="Par20">A double-blind randomized placebo-controlled cross-sectional study, where eleven normotensive subjects with no family history of essential hypertension were recruited, has found supplementation of miglyol rich in caprylic (8:0) and capric acids (10:0) results in decreased diastolic blood pressure (MacIver et al., <xref ref-type="bibr" rid="CR99">1990</xref>). Furthermore, rodent model studies have shown that SCFAs administration can decrease systolic blood pressure mediated by GPR41 expressed in vascular endothelium, while GPR41 knock out mice have isolated systolic hypertension compared with wild-type (WT) mice (Natarajan et al., <xref ref-type="bibr" rid="CR115">2016</xref>). Olfr78, a member of the G-protein-coupled receptor family expressed in vascular smooth muscle cells, contributes to blood pressure control as Olfr78-deficient mice showed hypertension (Miyamoto et al., <xref ref-type="bibr" rid="CR111">2016</xref>). Therefore, such causality studies including randomized controlled trial and instrumental rodent genetics model, have conclusively shown the pivotal role of SCFAs in blood pressure regulations.</p>
</sec>
<sec id="Sec5">
<title>PHYTOESTROGENS</title>
<p id="Par21">Phytoestrogens in plant can protect itself from attack by modulation of the fertility of plant predators, vertebrate herbivores (Hughes, <xref ref-type="bibr" rid="CR71">1988</xref>). Phytoestrogens are similar to human estrogens in structure. There are three main groups of phytoestrogens, isoflavones, ellagitannins and lignans (Gaya et al., <xref ref-type="bibr" rid="CR49">2108</xref>). In the gut, phytoestrogens can be further metabolized to more active molecules, such as equol, <italic>O</italic>-desmethylangolensin (<italic>O</italic>-DMA), dihydrodaidzein, dihydrogenistein, enterolactone and enterodiol (Fig. <xref ref-type="fig" rid="Fig4">4</xref>) (Gaya et al., <xref ref-type="bibr" rid="CR49">2108</xref>; Axelson and Setchell <xref ref-type="bibr" rid="CR9">1981</xref>; Wang et al., <xref ref-type="bibr" rid="CR165">2005</xref>). The biosynthesis pathway of enterolactone and enterodiol have been found from several bacterium strains metabolizing lignan (Vanharanta et al., <xref ref-type="bibr" rid="CR160">2003</xref>). Both pinoresinol and lariciresinol, precursors of enterolactone and enterodiol, are a structural moiety in lignin. Lignin is an abundant plant-derived polymer secondary to cellulose in amount in the earth (Vanharanta et al., <xref ref-type="bibr" rid="CR160">2003</xref>). Lignin can be degraded by gut microbiota to release lignans (DeAngelis et al., <xref ref-type="bibr" rid="CR32">2011</xref>). Equol and O-DMA can be metabolized from daidzein in the gut by several bacterium strains, such as <italic>Adlercreutzia equolifaciens</italic>, <italic>Eggerthella sp</italic>. YY7918, <italic>Lactococcus garvieae</italic>, <italic>Slackia equolifaciens</italic>, <italic>Slackia isoflavoniconvertens</italic>, <italic>Slackia sp</italic>. NATTS (Braune and Blaut, <xref ref-type="bibr" rid="CR19">2018</xref>; Guadamuro et al., <xref ref-type="bibr" rid="CR55">2017</xref>; Matthies et al., <xref ref-type="bibr" rid="CR103">2012</xref>; Frankenfeld et al., <xref ref-type="bibr" rid="CR45">2014</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Structural formulas of phytoesterogens and the metabolism pathways</bold>
</p></caption><graphic id="MO4" xlink:href="13238_2018_549_Fig4_HTML"></graphic></fig>
</p>
<p id="Par22">Phytoestrogens are reported to reduce breast cancer for postmenopausal women (Goodman et al., <xref ref-type="bibr" rid="CR52">2009</xref>). In animal model, pretreatment of phytoestrogen-rich, <italic>Pueraria mirifica</italic> tuberous powder resulted in decreasing the virulence of rat breast tumor development induced by 7,12-dimethylbenz(a)anthracene (Cherdshewasart et al., <xref ref-type="bibr" rid="CR23">2007</xref>). Besides breast cancer, phytoestrogens may have protective action against prostate, bowel and other cancers, cardiovascular disease, brain function disorders and osteoporosis (Zhang et al., <xref ref-type="bibr" rid="CR184">2016</xref>; Ward and Kuhnle <xref ref-type="bibr" rid="CR172">2010</xref>; Arbabi et al., <xref ref-type="bibr" rid="CR7">2016</xref>; Menze et al., <xref ref-type="bibr" rid="CR106">2015</xref>; Trieu and Uckun <xref ref-type="bibr" rid="CR150">1999</xref>; Chiechi et al., <xref ref-type="bibr" rid="CR26">1999</xref>; Wang et al., <xref ref-type="bibr" rid="CR167">2011</xref>; Zhang et al., <xref ref-type="bibr" rid="CR182">2004</xref>; Lephart et al., <xref ref-type="bibr" rid="CR89">2001</xref>). However, a few investigations implicate that the controversial role of phytoestrogens including increasing colorectal cancer and prostate cancer risk and indicate little supportive evidence of phytoestrogens decreasing cardiovascular disease risk (Ward et al., <xref ref-type="bibr" rid="CR173">2010</xref>; van der Schouw et al., <xref ref-type="bibr" rid="CR158">2005</xref>; Peterson et al., <xref ref-type="bibr" rid="CR122">2010</xref>).</p>
<p id="Par23">Enterolactone is a biphenol, which can function as anti-oxidant. A study shows that high serum enterolactone level is associated with reduced CVD mortality (Vanharanta et al., <xref ref-type="bibr" rid="CR160">2003</xref>). Furthermore, low serum enterolactone is associated with increased in vivo lipid peroxidation, assessed by plasma F2-isoprostane concentrations (Vanharanta et al., <xref ref-type="bibr" rid="CR159">2002</xref>). In addition, urinary total and individual phytoestrogens were significantly inversely associated with serum C-reactive protein (CRP; an inflammation biomarker) (Reger et al., <xref ref-type="bibr" rid="CR132">2017</xref>). Phytoestrogens can bind to estrogen receptors (Morito et al., <xref ref-type="bibr" rid="CR112">2001</xref>), which either mimics estrogen or works as antagonist (Fitzpatrick, <xref ref-type="bibr" rid="CR43">1999</xref>). Thus, the effects of phytoestrogens can be biphasic: for example, phytoestrogens both increases vasodilation and nitric oxide metabolism that may have a favorable impact on vascular health; on the other hand, phytoestrogen may also have some prothrombotic or proinflammatory effects that may offset other benefits (Herrington, <xref ref-type="bibr" rid="CR63">2000</xref>). Both enterolactone and enterodiol can alleviate the effect of peripheral blood lymphocytes activated by lipopolysaccharide (Corsini et al., <xref ref-type="bibr" rid="CR27">2010</xref>). Such lymphocytes activation leads to inhibitory-κB (I-κB) degradation and nuclear factor-κB (NF-κB) activation thereby resulting in TNF-α production (Corsini et al., <xref ref-type="bibr" rid="CR27">2010</xref>). Thus, both enterolactone and enterodiol may have pro-anti-inflammatory role.</p>
</sec>
<sec id="Sec6">
<title>ANTHOCYANINS</title>
<p id="Par24">Anthocyanins are glycosyl-anthocyanidins, widely distributed in plant vacuole with pH depending color. Anthocyanidins are flavones with different functional groups covalently linked to the three cycles. Anthocyanins have been found with beneficial effects on obesity and diabetes control, cardiovascular disease and cancer prevention, and visual and brain function improvement (Tsuda, <xref ref-type="bibr" rid="CR152">2012</xref>; Hannum, <xref ref-type="bibr" rid="CR58">2004</xref>). Mechanistically, the beneficial effect of anthocyanins on cardiovascular health include working as an antiplatelet agent in atherosclerosis and other CVD prevention, inducing nitric oxide formation in vessel thereby enhancing vasorelaxation, protecting cardiac cells from oxidative-stress-induced apoptosis, and increasing HDL cholesterol as well (Gaiz et al., <xref ref-type="bibr" rid="CR48">2018</xref>; Stoclet et al., <xref ref-type="bibr" rid="CR142">1999</xref>; Hassellund et al., <xref ref-type="bibr" rid="CR61">2013</xref>; Isaak et al., <xref ref-type="bibr" rid="CR73">2017</xref>).</p>
<p id="Par25">Further investigations have confirmed that the beneficial effect of some anthocyanins on atherosclerosis is mediated by gut microbiota metabolites. Ingested dietary anthocyanins are absorbed with a small part while large amounts are likely to enter the colon to be degraded by gut microbiota as free anthocyanidins and protocatechuic acid (PCA) (Fig. <xref ref-type="fig" rid="Fig5">5</xref>) (Aura et al., <xref ref-type="bibr" rid="CR8">2005</xref>). Anthocyanidin-3-glucoside promotes reverse cholesterol transport mediated by its gut microbiota metabolite, PCA. PCA can reduce macrophage miR-10b expression, therefore increasing ABCA1 and ABCG1 expression (Wang et al., <xref ref-type="bibr" rid="CR168">2012</xref>). Gallic acid (GA), one of the microbiota anthocyanin metabolites, has been shown increasing nitric oxide (NO) levels by increasing phosphorylation of endothelial nitric oxide synthase (eNOS) (Radtke et al., <xref ref-type="bibr" rid="CR128">2004</xref>). GA inhibited angiotensin-I converting enzyme (ACE), leading to reduced blood pressure in spontaneously hypertensive rats (SHR) comparable to captopril (Kang et al., <xref ref-type="bibr" rid="CR78">2015</xref>). These results suggest that GA isolated from <italic>Spirogyra sp</italic>. exerts multiple therapeutic effects and has a great potential for CVD intervention.<fig id="Fig5"><label>Figure 5</label><caption><p><bold>Colon microbes contribute to protocatechuic acid biosynthesis from diet anthocyanins</bold>. R<sub>3</sub>′ = H, OH or OCH<sub>3</sub>; R<sub>5</sub>′ = H, OH or OCH<sub>3</sub>; R<sub>5</sub> = OH or OCH<sub>3</sub>; R<sub>6</sub> = H or OH; R<sub>7</sub> = OH or OCH<sub>3</sub>. R<sub>5</sub>, R<sub>7</sub> can be glycosylated if it is a hydroxyl group</p></caption><graphic id="MO5" xlink:href="13238_2018_549_Fig5_HTML"></graphic></fig>
</p>
<p id="Par26">Anthocyanins can also modulate gut microbiota community structure. For example, malvidin-3-glucoside can enhance the growth of some beneficial bacterium such as <italic>Bifidobaterium</italic> spp. and <italic>Lactobacillus</italic> spp. (Hidalgo et al., <xref ref-type="bibr" rid="CR65">2012</xref>). On the other hand, gallic acid, one of the microbiota anthocyanin metabolites, can reduce some potentially harmful bacteria such as <italic>Clostridium histolyticum</italic>, without negative effect on beneficial bacteria (Hidalgo et al., <xref ref-type="bibr" rid="CR65">2012</xref>). Study on comparison in gut microbiota fingerprints between cardiovascular disease patients and healthy controls has shown that the diversity of beneficial bacteria was reduced in patients with cardiovascular disease (Vamanu et al., <xref ref-type="bibr" rid="CR157">2016</xref>). Thus, anthocyanins play critical role in shaping the microbiota taxonomic composition especially under CVD conditions.</p>
</sec>
<sec id="Sec7">
<title>BILE ACIDS</title>
<p id="Par27">Bile acids are synthesized from cholesterol in liver. The initial products are chenodeoxycholic acid (CDCA) and cholic acid (CA) (Fig. <xref ref-type="fig" rid="Fig6">6</xref>), and then conjugated with glycine or taurine, stored and concentrated in gallbladder (Wahlstrom et al., <xref ref-type="bibr" rid="CR163">2016</xref>; LaRusso et al., <xref ref-type="bibr" rid="CR88">1974</xref>). Bile acids produced in liver are called as primary bile acids. Bile acids are released into duodenum after meal to emulsify dietary fats and oils for digestion and help absorb lipid soluble vitamins (Danielsson, <xref ref-type="bibr" rid="CR29">1963</xref>; Hollander et al., <xref ref-type="bibr" rid="CR66">1977</xref>; Barnard and Heaton, <xref ref-type="bibr" rid="CR11">1973</xref>; Miettinen, <xref ref-type="bibr" rid="CR108">1971</xref>). In ileum, conjugated bile acids are then reabsorbed and carried in the portal blood to liver. This process is called enterohepatic circulation and preserves more than 95% of the bile acid pool (Wahlstrom et al., <xref ref-type="bibr" rid="CR163">2016</xref>). In distal ileum, conjugated bile acids are hydrolyzed to remove glycine or taurine by bile salt hydrolase in microbes to escape reuptake by apical sodium dependent bile acid transporter and dehydroxylated by microbes as deoxycholic acid or lithocholic acid, which are called as secondary bile acids (Fig. <xref ref-type="fig" rid="Fig6">6</xref><bold>)</bold>, (Wahlstrom et al., <xref ref-type="bibr" rid="CR163">2016</xref>; Chiang, <xref ref-type="bibr" rid="CR25">2009</xref>). The deconjugated bile acids are hydrophobic and it can be excreted as feces, which constitutes the last step of reverse cholesterol efflux to decrease circulating cholesterol (Dawson and Karpen, <xref ref-type="bibr" rid="CR30">2015</xref>), therefore the risk for atherosclerosis can be decreased.<fig id="Fig6"><label>Figure 6</label><caption><p>
<bold>The main bile acids and their metabolic pathways</bold>
</p></caption><graphic id="MO6" xlink:href="13238_2018_549_Fig6_HTML"></graphic></fig>
</p>
<p id="Par28">Bile acid can modulate gut microbiota composition by killing bacterium in a species and dosage dependent way (Yokota et al., <xref ref-type="bibr" rid="CR180">2012</xref>). Bile acids are associated with metabolic disease, obesity, diarrhea, inflammatory bowel disease, colorectal cancer and hepatocellular carcinoma as well (Joyce and Gahan, <xref ref-type="bibr" rid="CR76">2016</xref>).</p>
<p id="Par29">Bile acids can work as hormone to act on farnesoid X receptor (FXR) and G protein-coupled membrane receptor 5 (TGR5) to decrease triglyceride accumulation, fatty acid oxidation, decrease the expression of pro-inflammatory cytokines and chemokines in aorta through the inactivation of NF-κB (Levi, <xref ref-type="bibr" rid="CR91">2016</xref>; Porez et al., <xref ref-type="bibr" rid="CR125">2012</xref>).</p>
<p id="Par30">Gut microbiota can affect cardiovascular health via secondary bile acids, deoxycholic acid and lithocholic acid, both of which are the main ligand for TGR5 (Fiorucci et al., <xref ref-type="bibr" rid="CR42">2010</xref>; Duboc et al., <xref ref-type="bibr" rid="CR39">2014</xref>). Primary bile acids including chenodeoxycholic acid and cholic acid, with FXR as their the receptor, have distinct effects on cardiac health when compared to secondary bile acids (Fiorucci et al., <xref ref-type="bibr" rid="CR42">2010</xref>). Consistently, the serum level of primary bile acids were found decreased while ratios of secondary bile acids to primary bile acids were increased in cardiovascular disease patients compared to healthy controls (Mayerhofer et al., <xref ref-type="bibr" rid="CR104">2017</xref>).</p>
</sec>
<sec id="Sec8">
<title>LIPOPOLYSACCHARIDE</title>
<p id="Par31">Distinguished from the abovementioned gut microbiota derived metabolites, lipopolysaccharide (LPS, also called as endotoxin) is a component of outer-membrane of Gram-negative bacteria with a very complicated structural formula composed of lipid and saccharide. LPS is released from the bacterial membrane after destruction with the capacity of inducing systemic inflammation and sepsis (Beutler and Rietschel, <xref ref-type="bibr" rid="CR14">2003</xref>). For healthy subjects, gut-blood barrier prevents LPS entering circulating blood. However, the gut-blood barrier leak due to dysbiosis results in bacterium entering the bloodstream. For the periodontal patients, bacterium can directly enter circulating blood, leading to increased levels of circulating LPS (Fukui et al., <xref ref-type="bibr" rid="CR46">1991</xref>; Wang et al., <xref ref-type="bibr" rid="CR171">2015</xref>; de Punder and Pruimboom, <xref ref-type="bibr" rid="CR31">2015</xref>; Lakio et al., <xref ref-type="bibr" rid="CR87">2006</xref>).</p>
<p id="Par32">LPS can induce foam cell formation and cholesteryl ester accumulation from native low density lipoprotein, indicating LPS is proatherogenic (Lakio et al., <xref ref-type="bibr" rid="CR87">2006</xref>; Funk et al., <xref ref-type="bibr" rid="CR47">1993</xref>). LPS induces CD14 and SR-AI expression in macrophages via JNK1, leading to oxLDL uptake and foam cell formation (An et al., <xref ref-type="bibr" rid="CR3">2017</xref>). LPS binding protein (LBP) is synthesized in liver and released to circulating blood (Schumann et al., <xref ref-type="bibr" rid="CR137">1990</xref>). Serum LBP level in patients with angiographically confirmed coronary artery disease (CAD) found significantly higher than controls without CAD is an independent predictive biomarker for total and cardiovascular mortality (Lepper et al., <xref ref-type="bibr" rid="CR90">2011</xref>). Moreover, the high affinity binding complex of LPS-LBP binds to monocyte and macrophage, triggering the secretion of tumor necrosis factor (Schumann et al., <xref ref-type="bibr" rid="CR137">1990</xref>). Toll-like receptor 4 (TLR4) is the membrane receptor of LPS, when activated, triggering NF-κB signaling and producing proinflammatory cytokines (Lu et al., <xref ref-type="bibr" rid="CR98">2008</xref>). Further, inflammatory caspase-4, -5 and -11 directly recognize bacterial LPS, both of which trigger pyroptosis (Shi et al., <xref ref-type="bibr" rid="CR140">2015</xref>). Low serum selenium or selenoprotein P (SePP) levels have been repetitively observed in severe sepsis, and both purified SePP and synthetic peptides corresponding to the His-rich motifs neutralized LPS (Zhao et al., <xref ref-type="bibr" rid="CR186">2016</xref>). Very recently, a study shows itaconate is required for the activation of the anti-inflammatory transcription factor Nrf2 (also known as NFE2L2) by lipopolysaccharide in mouse and human macrophages via dicarboxylation of KEAP1 (Mills et al., <xref ref-type="bibr" rid="CR110">2018</xref>). Taken together, LPS is a mechanistic biomarker for CAD.</p>
</sec>
<sec id="Sec9">
<title>PROSPECT</title>
<p id="Par33">More and more gut microbiota derived metabolites have been unveiled as crucial factor contributing to cardiovascular health and disease. Thus, a better understanding of the gut microbe pathways involved in the biosynthesis of CVD related metabolites would greatly facilitate managing cardiac health especially preventing CVD.</p>
<p id="Par34">Apparently, for mechanistic biomarker discovery and CVD management, it is of primary importance to pinpoint the causal role of gut microbiota derived metabolites. Koch’s postulate, which states that a given pathogen leads to a distinct disease, have been evolving into molecular and ecological Koch’s postulate including CVD (Vonaesch et al., <xref ref-type="bibr" rid="CR162">2018</xref>). Therefore, many ongoing efforts have been focusing on the causality of gut microbiota derived metabolites in CVD. Key methodologies include randomized controlled trials (Tang et al., <xref ref-type="bibr" rid="CR146">2013</xref>; Panigrahi et al., <xref ref-type="bibr" rid="CR119">2017</xref>), Mendelian randomization approach (Mendelson et al., <xref ref-type="bibr" rid="CR105">2017</xref>) and gnotobiotic animal models (Hibberd et al., <xref ref-type="bibr" rid="CR64">2017</xref>).</p>
<p id="Par35">Given that diet is the most important factor shaping the dynamics of gut microbiotia (Rothschild et al., <xref ref-type="bibr" rid="CR134">2018</xref>), integrative studies on diet shaped microbiota-host interactions have the potential to offer us novel insight on CVD mechanisms. From the microbiota side, there is big room to study molecular genetics mechanisms by which how the physiology and pathology relevant microbiota taxonomic and functional profiles are regulated. Of note, studies on the immune mechanisms of CVD allow us to connect gut microbiota derived metabolites to key immune components of distinct immune cell and cytokine profile dynamics. We envision discovering predicative mechanistic CVD microbiome biomarkers and exploiting the probiotics and prebiotics therapeutics continue to be of primary priority.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec10">
<p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13238_2018_549_MOESM1_ESM.xlsx"><caption><p>Supplementary material 1 (XLSX 15 kb)</p></caption></media></supplementary-material></p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1007/s13238-018-0549-0) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>Z. Wang is supported by grants from the National Institutes of Health and the Office of Dietary Supplements (R01HL130819).</p>
<sec id="FPar1">
<title>ABBREVIATIONS</title>
<p id="Par36">ACE, angiotensin-I converting enzyme; CA, cholic acid; CDCA, chenodeoxycholic acid; CKD, chronic kidney disease; cntA/B, carnitine monooxygenase; cutC/D, choline-TMA lyase; CVD, cardiovascular disease; DMB, 3,3-dimethylbutanol; eNOS, endothelial nitric oxide synthase; ER, endoplasmic reticulum; FMOs, flavin monooxygenase; GA, gallic acid; IBD, inflammatory bowel disease; ICAM-1, intercellular adhesion molecule-1; I-κB, inhibitory-κB; LPS, lipopolysaccharide; MCP-1, monocyte chemotactic protein-1; NF-κB, nuclear factor-κB; NO, nitric oxide; O-DMA, O-desmethylangolensin; PCA, protocatechuic acid; SCFAs, short chain fatty acids; SHR, spontaneously hypertensive rats; TLR4, Toll-like receptor 4; TMA, trimethylamine; TMAO, trimethylamine-<italic>N</italic>-oxide; TNF-α, tumor necrosis factor-α.</p>
</sec>
<sec id="FPar2">
<title>COMPLIANCE WITH ETHICS GUIDELINES</title>
<p id="Par37">Zeneng Wang is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, and has the right to receive royalty payment for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab or Proctor &amp; Gamble. Yongzhong Zhao declares that he has no conflict of interest. This article does not contain any studies with human or animal subjects performed by the any of the authors.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrams</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An inulin-type fructan enhances calcium absorption primarily via an effect on colonic absorption in humans</article-title>
<source/>J Nutr
          <year>2007</year>
<volume>137</volume>
<fpage>2208</fpage>
<lpage>2212</lpage>
<pub-id pub-id-type="pmid">17884999</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tunaru</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Offermanns</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors</article-title>
<source/>Trends Pharmacol Sci
          <year>2009</year>
<volume>30</volume>
<fpage>557</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">19837462</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>JNK1 mediates lipopolysaccharide-induced CD14 and SR-AI expression and macrophage foam cell formation</article-title>
<source/>Front Physiol
          <year>2017</year>
<volume>8</volume>
<fpage>1075</fpage>
<pub-id pub-id-type="pmid">29354064</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andreesen</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Glycine metabolism in anaerobes</article-title>
<source/>Antonie Van Leeuwenhoek
          <year>1994</year>
<volume>66</volume>
<fpage>223</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="pmid">7747933</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anhe</surname>
<given-names>FF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts</article-title>
<source/>Curr Obes Rep
          <year>2015</year>
<volume>4</volume>
<fpage>389</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">26343880</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoki</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of indoxyl sulfate as a predisposing factor for atrial fibrillation in renal dysfunction</article-title>
<source/>J Am Heart Assoc
          <year>2015</year>
<volume>4</volume>
<fpage>e002023</fpage>
<pub-id pub-id-type="pmid">26452986</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arbabi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hamidi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Talaei</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Salami</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of Parkinsonism</article-title>
<source/>Iran J Basic Med Sci
          <year>2016</year>
<volume>19</volume>
<fpage>1285</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="pmid">28096960</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aura</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vitro metabolism of anthocyanins by human gut microflora</article-title>
<source/>Eur J Nutr
          <year>2005</year>
<volume>44</volume>
<fpage>133</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">15309431</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Axelson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Setchell</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>The excretion of lignans in rats—evidence for an intestinal bacterial source for this new group of compounds</article-title>
<source/>FEBS Lett
          <year>1981</year>
<volume>123</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">6262113</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakken</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Polgreen</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Beekmann</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Riedo</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Streit</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians</article-title>
<source/>Anaerobe
          <year>2013</year>
<volume>24</volume>
<fpage>20</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">24012687</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnard</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Heaton</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>Bile acids and vitamin A absorption in man: the effects of two bile acid-binding agents, cholestyramine and lignin</article-title>
<source/>Gut
          <year>1973</year>
<volume>14</volume>
<fpage>316</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="pmid">4706914</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battson</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suppression of gut dysbiosis reverses western diet-induced vascular dysfunction</article-title>
<source/>Am J Physiol Endocrinol Metab
          <year>2017</year>
<pub-id pub-id-type="pmid">29351482</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennett</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylamine-<italic>N</italic>-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation</article-title>
<source/>Cell Metab
          <year>2013</year>
<volume>17</volume>
<fpage>49</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">23312283</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beutler</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rietschel</surname>
<given-names>ET</given-names>
</name>
</person-group>
<article-title>Innate immune sensing and its roots: the story of endotoxin</article-title>
<source/>Nat Rev Immunol
          <year>2003</year>
<volume>3</volume>
<fpage>169</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">12563300</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattarai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kashyap</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Germ-free mice model for studying host–microbial interactions</article-title>
<source/>Methods Mol Biol
          <year>2016</year>
<volume>1438</volume>
<fpage>123</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="pmid">27150088</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bodea</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Funk</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Balskus</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Drennan</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Molecular basis of C–N bond cleavage by the glycyl radical enzyme choline trimethylamine-lyase</article-title>
<source/>Cell Chem Biol
          <year>2016</year>
<volume>23</volume>
<fpage>1206</fpage>
<lpage>1216</lpage>
<pub-id pub-id-type="pmid">27642068</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boets</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quantification of in vivo colonic short chain fatty acid production from inulin</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<fpage>8916</fpage>
<lpage>8929</lpage>
<pub-id pub-id-type="pmid">26516911</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boini</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Koka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Trimethylamine-<italic>N</italic>-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction</article-title>
<source/>Cell Physiol Biochem
          <year>2017</year>
<volume>44</volume>
<fpage>152</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="pmid">29130962</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braune</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blaut</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Evaluation of inter-individual differences in gut bacterial isoflavone bioactivation in humans by PCR-based targeting of genes involved in equol formation</article-title>
<source/>J Appl Microbiol
          <year>2018</year>
<volume>124</volume>
<fpage>220</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">29055162</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Faller</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Spanjaard</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?</article-title>
<source/>Curr Cancer Drug Targ
          <year>2003</year>
<volume>3</volume>
<fpage>219</fpage>
<lpage>236</lpage>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resveratrol attenuates trimethylamine-<italic>N</italic>-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota</article-title>
<source/>MBio
          <year>2016</year>
<volume>7</volume>
<fpage>e02210</fpage>
<lpage>e02215</lpage>
<pub-id pub-id-type="pmid">27048804</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylamine-<italic>N</italic>-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway</article-title>
<source/>J Am Heart Assoc
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherdshewasart</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Panriansaen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Picha</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERalpha and ERbeta</article-title>
<source/>Maturitas
          <year>2007</year>
<volume>58</volume>
<fpage>174</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="pmid">17870258</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherrington</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hinton</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Chopra</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Short-chain organic acids at ph 5.0 kill <italic>Escherichia coli</italic> and <italic>Salmonella</italic> spp. without causing membrane perturbation</article-title>
<source/>J Appl Bacteriol
          <year>1991</year>
<volume>70</volume>
<fpage>161</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">1902205</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>Bile acids: regulation of synthesis</article-title>
<source/>J Lipid Res
          <year>2009</year>
<volume>50</volume>
<fpage>1955</fpage>
<lpage>1966</lpage>
<pub-id pub-id-type="pmid">19346330</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiechi</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Lobascio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grillo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valerio</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Phytoestrogen-containing food and prevention of postmenopausal osteoporosis and cardiovascular diseases</article-title>
<source/>Minerva Ginecol
          <year>1999</year>
<volume>51</volume>
<fpage>343</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">10575902</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corsini</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-kappaB (NF-kappaB) signaling</article-title>
<source/>J Agric Food Chem
          <year>2010</year>
<volume>58</volume>
<fpage>6678</fpage>
<lpage>6684</lpage>
<pub-id pub-id-type="pmid">20446732</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craciun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Balskus</surname>
<given-names>EP</given-names>
</name>
</person-group>
<article-title>Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes</article-title>
<source/>ACS Chem Biol
          <year>2014</year>
<volume>9</volume>
<fpage>1408</fpage>
<lpage>1413</lpage>
<pub-id pub-id-type="pmid">24854437</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danielsson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Influence of bile acids on digestion and absorption of lipids</article-title>
<source/>Am J Clin Nutr
          <year>1963</year>
<volume>12</volume>
<fpage>214</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="pmid">14024951</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawson</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Karpen</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Intestinal transport and metabolism of bile acids</article-title>
<source/>J Lipid Res
          <year>2015</year>
<volume>56</volume>
<fpage>1085</fpage>
<lpage>1099</lpage>
<pub-id pub-id-type="pmid">25210150</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Punder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pruimboom</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability</article-title>
<source/>Front Immunol
          <year>2015</year>
<volume>6</volume>
<fpage>223</fpage>
<pub-id pub-id-type="pmid">26029209</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeAngelis</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of trapped lignin-degrading microbes in tropical forest soil</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e19306</fpage>
<pub-id pub-id-type="pmid">21559391</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeGruttola</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Current understanding of dysbiosis in disease in human and animal models</article-title>
<source/>Inflamm Bowel Dis
          <year>2016</year>
<volume>22</volume>
<fpage>1137</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="pmid">27070911</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ruas-Madiedo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Probiotic and technological properties of <italic>Lactobacillus</italic> spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis</article-title>
<source/>Front Microbiol
          <year>2014</year>
<pub-id pub-id-type="pmid">25642213</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>den Besten</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<fpage>e107392</fpage>
<pub-id pub-id-type="pmid">25203112</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>den Besten</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor gamma and glucagon-like peptide-1</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0136364</fpage>
<pub-id pub-id-type="pmid">26292284</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devlin</surname>
<given-names>AS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota</article-title>
<source/>Cell Host Microbe
          <year>2016</year>
<volume>20</volume>
<fpage>709</fpage>
<lpage>715</lpage>
<pub-id pub-id-type="pmid">27916477</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolphin</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Shephard</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>IR</given-names>
</name>
</person-group>
<article-title>Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA</article-title>
<source/>Genomics
          <year>1997</year>
<volume>46</volume>
<fpage>260</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="pmid">9417913</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duboc</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tache</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>The bile acid TGR5 membrane receptor: from basic research to clinical application</article-title>
<source/>Dig Liver Dis
          <year>2014</year>
<volume>46</volume>
<fpage>302</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="pmid">24411485</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>The role of pH in determining the species composition of the human colonic microbiota</article-title>
<source/>Environ Microbiol
          <year>2009</year>
<volume>11</volume>
<fpage>2112</fpage>
<lpage>2122</lpage>
<pub-id pub-id-type="pmid">19397676</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut</article-title>
<source/>Curr Protein Pept Sci
          <year>2015</year>
<volume>16</volume>
<fpage>646</fpage>
<lpage>654</lpage>
<pub-id pub-id-type="pmid">26122784</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorucci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cipriani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baldelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mencarelli</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Bile acid-activated receptors in the treatment of dyslipidemia and related disorders</article-title>
<source/>Prog Lipid Res
          <year>2010</year>
<volume>49</volume>
<fpage>171</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">19932133</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzpatrick</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women</article-title>
<source/>Mayo Clin Proc
          <year>1999</year>
<volume>74</volume>
<fpage>601</fpage>
<lpage>607</lpage>
<pub-id pub-id-type="pmid">10377937</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Links between diet, gut microbiota composition and gut metabolism</article-title>
<source/>Proc Nutr Soc
          <year>2015</year>
<volume>74</volume>
<fpage>13</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">25268552</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frankenfeld</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wahala</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lampe</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Obesity prevalence in relation to gut microbial environments capable of producing equol or <italic>O</italic>-desmethylangolensin from the isoflavone daidzein</article-title>
<source/>Eur J Clin Nutr
          <year>2014</year>
<volume>68</volume>
<fpage>526</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">24569543</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brauner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay</article-title>
<source/>J Hepatol
          <year>1991</year>
<volume>12</volume>
<fpage>162</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="pmid">2050995</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funk</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Feingold</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Grunfeld</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation</article-title>
<source/>Atherosclerosis
          <year>1993</year>
<volume>98</volume>
<fpage>67</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">8457252</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<mixed-citation publication-type="other">Gaiz AA, Mosawy S, Colson N, Singh I (2018) Potential of anthocyanin to prevent cardiovascular disease in diabetes. Altern Ther Health Med</mixed-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaya</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanchez-Jimenez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landete</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Phytoestrogen metabolism by adult human gut microbiota</article-title>
<source/>Molecules
          <year>2016</year>
<pub-id pub-id-type="pmid">27517891</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glassock</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Uremic toxins: what are they? An integrated overview of pathobiology and classification</article-title>
<source/>J Ren Nutr
          <year>2008</year>
<volume>18</volume>
<fpage>2</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">18089436</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzaga-Jauregui</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Human genome sequencing in health and disease</article-title>
<source/>Annu Rev Med
          <year>2012</year>
<volume>63</volume>
<fpage>35</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">22248320</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study</article-title>
<source/>Cancer Prev Res (Phila)
          <year>2009</year>
<volume>2</volume>
<fpage>887</fpage>
<lpage>894</lpage>
<pub-id pub-id-type="pmid">19789300</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transmission of atherosclerosis susceptibility with gut microbial transplantation</article-title>
<source/>J Biol Chem
          <year>2015</year>
<volume>290</volume>
<fpage>5647</fpage>
<lpage>5660</lpage>
<pub-id pub-id-type="pmid">25550161</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gryp</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vanholder</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vaneechoutte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glorieux</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>p-Cresyl sulfate</article-title>
<source/>Toxins (Basel)
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guadamuro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dohrmann</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Tebbe</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones</article-title>
<source/>BMC Microbiol
          <year>2017</year>
<volume>17</volume>
<fpage>93</fpage>
<pub-id pub-id-type="pmid">28415978</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2017</year>
<volume>312</volume>
<fpage>G474</fpage>
<lpage>G487</lpage>
<pub-id pub-id-type="pmid">28280143</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes</article-title>
<source/>J Am Heart Assoc
          <year>2015</year>
<volume>4</volume>
<fpage>e001852</fpage>
<pub-id pub-id-type="pmid">26066032</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannum</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Potential impact of strawberries on human health: a review of the science</article-title>
<source/>Crit Rev Food Sci Nutr
          <year>2004</year>
<volume>44</volume>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">15077879</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrold</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice</article-title>
<source/>Appetite
          <year>2013</year>
<volume>62</volume>
<fpage>84</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">23207186</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashemi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fouhse</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Willing</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Dietary pea fiber supplementation improves glycemia and induces changes in the composition of gut microbiota, serum short-chain fatty acid profile and expression of mucins in glucose intolerant rats</article-title>
<source/>Nutrient
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassellund</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study</article-title>
<source/>J Hum Hypertens
          <year>2013</year>
<volume>27</volume>
<fpage>100</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">22336903</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heerdt</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Houston</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Augenlicht</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function</article-title>
<source/>Cell Growth Differ
          <year>1997</year>
<volume>8</volume>
<fpage>523</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="pmid">9149903</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrington</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection</article-title>
<source/>Can J Cardiol
          <year>2000</year>
<volume>16</volume>
<issue>Suppl E</issue>
<fpage>5E</fpage>
<lpage>9E</lpage>
<pub-id pub-id-type="pmid">10906617</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hibberd</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of micronutrient deficiencies on bacterial species from the human gut microbiota</article-title>
<source/>Sci Transl Med
          <year>2017</year>
<pub-id pub-id-type="pmid">28515336</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidalgo</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolism of anthocyanins by human gut microflora and their influence on gut bacterial growth</article-title>
<source/>J Agric Food Chem
          <year>2012</year>
<volume>60</volume>
<fpage>3882</fpage>
<lpage>3890</lpage>
<pub-id pub-id-type="pmid">22439618</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollander</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ruble</surname>
<given-names>PE</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Vitamin K2 colonic and ileal in vivo absorption: bile, fatty acids, and pH effects on transport</article-title>
<source/>Am J Physiol
          <year>1977</year>
<volume>233</volume>
<fpage>E124</fpage>
<lpage>E129</lpage>
<pub-id pub-id-type="pmid">18938</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoverstad</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Midtvedt</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acids in germfree mice and rats</article-title>
<source/>J Nutr
          <year>1986</year>
<volume>116</volume>
<fpage>1772</fpage>
<lpage>1776</lpage>
<pub-id pub-id-type="pmid">3761032</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoverstad</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Midtvedt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bohmer</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acids in intestinal content of germfree mice monocontaminated with <italic>Escherichia coli</italic> or <italic>Clostridium difficile</italic></article-title>
<source/>Scand J Gastroenterol
          <year>1985</year>
<volume>20</volume>
<fpage>373</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="pmid">3890142</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>CC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Levels of indoxyl sulfate are associated with severity of coronary atherosclerosis</article-title>
<source/>Clin Invest Med
          <year>2013</year>
<volume>36</volume>
<fpage>E42</fpage>
<lpage>E49</lpage>
<pub-id pub-id-type="pmid">23374599</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>e16221</fpage>
<pub-id pub-id-type="pmid">21283757</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>CL</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens</article-title>
<source/>Environ Health Perspect
          <year>1988</year>
<volume>78</volume>
<fpage>171</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">3203635</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Tarng</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease</article-title>
<source/>J Am Heart Assoc
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isaak</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Petkau</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Blewett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Karmin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Siow</surname>
<given-names>YL</given-names>
</name>
</person-group>
<article-title>Lingonberry anthocyanins protect cardiac cells from oxidative-stress-induced apoptosis</article-title>
<source/>Can J Physiol Pharmacol
          <year>2017</year>
<volume>95</volume>
<fpage>904</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="pmid">28384410</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ezawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsuruta</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Correlation between serum levels of protein-bound uremic toxins in hemodialysis patients measured by LC/MS/MS</article-title>
<source/>Mass Spectrom (Tokyo)
          <year>2013</year>
<volume>2</volume>
<fpage>S0017</fpage>
<pub-id pub-id-type="pmid">24349936</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname>
<given-names>YJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/-mice</article-title>
<source/>Kidney Int
          <year>2016</year>
<volume>89</volume>
<fpage>439</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="pmid">26466319</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joyce</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Gahan</surname>
<given-names>CG</given-names>
</name>
</person-group>
<article-title>Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health</article-title>
<source/>Annu Rev Food Sci Technol
          <year>2016</year>
<volume>7</volume>
<fpage>313</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="pmid">26772409</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalnins</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure and function of CutC choline lyase from human microbiota bacterium <italic>Klebsiella pneumoniae</italic></article-title>
<source/>J Biol Chem
          <year>2015</year>
<volume>290</volume>
<fpage>21732</fpage>
<lpage>21740</lpage>
<pub-id pub-id-type="pmid">26187464</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gallic acid isolated from <italic>Spirogyra</italic> sp. improves cardiovascular disease through a vasorelaxant and antihypertensive effect</article-title>
<source/>Environ Toxicol Pharmacol
          <year>2015</year>
<volume>39</volume>
<fpage>764</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="pmid">25727171</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karaki</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of the short-chain fatty acid receptor, GPR43, in the human colon</article-title>
<source/>J Mol Histol
          <year>2008</year>
<volume>39</volume>
<fpage>135</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">17899402</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasubuchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ichimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<fpage>2839</fpage>
<lpage>2849</lpage>
<pub-id pub-id-type="pmid">25875123</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Applications of inulin and oligofructose in health and nutrition</article-title>
<source/>J Biosci
          <year>2002</year>
<volume>27</volume>
<fpage>703</fpage>
<lpage>714</lpage>
<pub-id pub-id-type="pmid">12571376</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeth</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota metabolism of <sc>l</sc>-carnitine, a nutrient in red meat, promotes atherosclerosis</article-title>
<source/>Nat Med
          <year>2013</year>
<volume>19</volume>
<fpage>576</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">23563705</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeth</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of <sc>l</sc>-carnitine to TMAO</article-title>
<source/>Cell Metab
          <year>2014</year>
<volume>20</volume>
<fpage>799</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="pmid">25440057</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kouchaki</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial</article-title>
<source/>Clin Nutr
          <year>2017</year>
<volume>36</volume>
<fpage>1245</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="pmid">27669638</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stecher</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets</article-title>
<source/>Mol Biol Evol
          <year>2016</year>
<volume>33</volume>
<fpage>1870</fpage>
<lpage>1874</lpage>
<pub-id pub-id-type="pmid">27004904</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kummen</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated trimethylamine-<italic>N</italic>-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function</article-title>
<source/>United Eur Gastroenterol J
          <year>2017</year>
<volume>5</volume>
<fpage>532</fpage>
<lpage>541</lpage>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakio</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen <italic>Actinobacillus actinomycetemcomitans</italic></article-title>
<source/>J Endotoxin Res
          <year>2006</year>
<volume>12</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="pmid">16420744</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaRusso</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Korman</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption</article-title>
<source/>N Engl J Med
          <year>1974</year>
<volume>291</volume>
<fpage>689</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="pmid">4851463</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lephart</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Adlercreutz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Dietary soy phytoestrogen effects on brain structure and aromatase in Long-Evans rats</article-title>
<source/>NeuroReport
          <year>2001</year>
<volume>12</volume>
<fpage>3451</fpage>
<lpage>3455</lpage>
<pub-id pub-id-type="pmid">11733689</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepper</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease–results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC)</article-title>
<source/>Atherosclerosis
          <year>2011</year>
<volume>219</volume>
<fpage>291</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">21722903</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Role of bile acid-regulated nuclear receptor FXR and G protein-coupled receptor TGR5 in regulation of cardiorenal syndrome (Cardiovascular Disease and Chronic Kidney Disease)</article-title>
<source/>Hypertension
          <year>2016</year>
<volume>67</volume>
<fpage>1080</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="pmid">27045028</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrated catalog of reference genes in the human gut microbiome</article-title>
<source/>Nat Biotechnol
          <year>2014</year>
<volume>32</volume>
<fpage>834</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="pmid">24997786</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szajewska</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials</article-title>
<source/>Ann Nutr Metab
          <year>2013</year>
<volume>63</volume>
<fpage>42</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">23887189</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p-Cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients</article-title>
<source/>Biomed Res Int
          <year>2014</year>
<volume>2014</volume>
<fpage>526932</fpage>
<pub-id pub-id-type="pmid">24592393</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon</article-title>
<source/>J Bacteriol
          <year>2004</year>
<volume>186</volume>
<fpage>2099</fpage>
<lpage>2106</lpage>
<pub-id pub-id-type="pmid">15028695</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holtrop</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene</article-title>
<source/>Environ Microbiol
          <year>2010</year>
<volume>12</volume>
<fpage>304</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">19807780</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hold</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>The gut microbiota, bacterial metabolites and colorectal cancer</article-title>
<source/>Nat Rev Microbiol
          <year>2014</year>
<volume>12</volume>
<fpage>661</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="pmid">25198138</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>LPS/TLR4 signal transduction pathway</article-title>
<source/>Cytokine
          <year>2008</year>
<volume>42</volume>
<fpage>145</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">18304834</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacIver</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>McNally</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Ollerenshaw</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sheldon</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Heagerty</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>The effect of short-chain fatty acid supplementation on membrane electrolyte transport and blood pressure</article-title>
<source/>J Hum Hypertens
          <year>1990</year>
<volume>4</volume>
<fpage>485</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="pmid">2283638</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manrique Vergara</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gonzalez Sanchez</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Short chain fatty acids (butyric acid) and intestinal diseases</article-title>
<source/>Nutr Hosp
          <year>2017</year>
<volume>34</volume>
<fpage>58</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">29156934</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mardis</surname>
<given-names>ER</given-names>
</name>
</person-group>
<article-title>Next-generation DNA sequencing methods</article-title>
<source/>Annu Rev Genomics Hum Genet
          <year>2008</year>
<volume>9</volume>
<fpage>387</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">18576944</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-del Campo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria</article-title>
<source/>MBio
          <year>2015</year>
<pub-id pub-id-type="pmid">25873372</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matthies</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blaut</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Braune</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats</article-title>
<source/>J Nutr
          <year>2012</year>
<volume>142</volume>
<fpage>40</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">22113864</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayerhofer</surname>
<given-names>CCK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased secondary/primary bile acid ratio in chronic heart failure</article-title>
<source/>J Card Fail
          <year>2017</year>
<volume>23</volume>
<fpage>666</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">28688889</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendelson</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of Body Mass Index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease: a Mendelian randomization approach</article-title>
<source/>PLoS Med
          <year>2017</year>
<volume>14</volume>
<fpage>e1002215</fpage>
<pub-id pub-id-type="pmid">28095459</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menze</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Esmat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tadros</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Abdel-Naim</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Khalifa</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0117223</fpage>
<pub-id pub-id-type="pmid">25675218</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Hostetter</surname>
<given-names>TH</given-names>
</name>
</person-group>
<article-title>Uremic solutes from colon microbes</article-title>
<source/>Kidney Int
          <year>2012</year>
<volume>81</volume>
<fpage>949</fpage>
<lpage>954</lpage>
<pub-id pub-id-type="pmid">22318422</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miettinen</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Relationship between faecal bile acids, absorption of fat and vitamin B 12, and serum lipids in patients with ileal resections</article-title>
<source/>Eur J Clin Invest
          <year>1971</year>
<volume>1</volume>
<fpage>452</fpage>
<lpage>460</lpage>
<pub-id pub-id-type="pmid">5121736</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Wolin</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora</article-title>
<source/>Appl Environ Microbiol
          <year>1996</year>
<volume>62</volume>
<fpage>1589</fpage>
<lpage>1592</lpage>
<pub-id pub-id-type="pmid">8633856</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname>
<given-names>EL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</article-title>
<source/>Nature
          <year>2018</year>
<volume>556</volume>
<fpage>113</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">29590092</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyamoto</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of short-chain fatty acid on blood pressure regulation</article-title>
<source/>Curr Opin Nephrol Hypertens
          <year>2016</year>
<volume>25</volume>
<fpage>379</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="pmid">27490782</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morito</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interaction of phytoestrogens with estrogen receptors alpha and beta</article-title>
<source/>Biol Pharm Bull
          <year>2001</year>
<volume>24</volume>
<fpage>351</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="pmid">11305594</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moss</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Ramji</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Nutraceutical therapies for atherosclerosis</article-title>
<source/>Nat Rev Cardiol
          <year>2016</year>
<volume>13</volume>
<fpage>513</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="pmid">27383080</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nallu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ramezani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Muralidharan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Gut microbiome in chronic kidney disease: challenges and opportunities</article-title>
<source/>Transl Res
          <year>2017</year>
<volume>179</volume>
<fpage>24</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">27187743</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natarajan</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial short-chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41</article-title>
<source/>Physiol Genomics
          <year>2016</year>
<volume>48</volume>
<fpage>826</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="pmid">27664183</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Kotarsky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Owman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Olde</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids</article-title>
<source/>Biochem Biophys Res Commun
          <year>2003</year>
<volume>303</volume>
<fpage>1047</fpage>
<lpage>1052</lpage>
<pub-id pub-id-type="pmid">12684041</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oellgaard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Winther</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Rossing</surname>
<given-names>P</given-names>
</name>
<name>
<surname>von Scholten</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Trimethylamine <italic>N</italic>-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer</article-title>
<source/>Curr Pharm Des
          <year>2017</year>
<volume>23</volume>
<fpage>3699</fpage>
<lpage>3712</lpage>
<pub-id pub-id-type="pmid">28641532</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paasche</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation: an innovative approach to treating Clostridium difficile disease</article-title>
<source/>JAAPA
          <year>2013</year>
<volume>26</volume>
<fpage>46</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="pmid">24049940</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panigrahi</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized synbiotic trial to prevent sepsis among infants in rural India</article-title>
<source/>Nature
          <year>2017</year>
<volume>548</volume>
<fpage>407</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="pmid">28813414</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pascal</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Burini</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Chippaux</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Regulation of the trimethylamine <italic>N</italic>-oxide (TMAO) reductase in <italic>Escherichia coli</italic>: analysis of tor:: Mud1 operon fusion</article-title>
<source/>Mol Gen Genet
          <year>1984</year>
<volume>195</volume>
<fpage>351</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">6387391</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira-Fantini</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unravelling the metabolic impact of SBS-associated microbial dysbiosis: insights from the piglet short bowel syndrome model</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>43326</fpage>
<pub-id pub-id-type="pmid">28230078</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary lignans: physiology and potential for cardiovascular disease risk reduction</article-title>
<source/>Nutr Rev
          <year>2010</year>
<volume>68</volume>
<fpage>571</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="pmid">20883417</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluznick</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A novel SCFA receptor, the microbiota, and blood pressure regulation</article-title>
<source/>Gut Microbes
          <year>2014</year>
<volume>5</volume>
<fpage>202</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="pmid">24429443</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluznick</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2013</year>
<volume>110</volume>
<fpage>4410</fpage>
<lpage>4415</lpage>
<pub-id pub-id-type="pmid">23401498</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Prawitt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Staels</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease</article-title>
<source/>J Lipid Res
          <year>2012</year>
<volume>53</volume>
<fpage>1723</fpage>
<lpage>1737</lpage>
<pub-id pub-id-type="pmid">22550135</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prohaszka</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jayarao</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Fabian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The role of intestinal volatile fatty acids in the Salmonella shedding of pigs</article-title>
<source/>Zentralbl Vet B
          <year>1990</year>
<volume>37</volume>
<fpage>570</fpage>
<lpage>574</lpage>
</element-citation>
</ref>
<ref id="CR127">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>
<source/>Nature
          <year>2010</year>
<volume>464</volume>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">20203603</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radtke</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Kiderlen</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Kayser</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kolodziej</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Gene expression profiles of inducible nitric oxide synthase and cytokines in Leishmania major-infected macrophage-like RAW 264.7 cells treated with gallic acid</article-title>
<source/>Planta Med
          <year>2004</year>
<volume>70</volume>
<fpage>924</fpage>
<lpage>928</lpage>
<pub-id pub-id-type="pmid">15490320</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raspor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Goranovic</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Biotechnological applications of acetic acid bacteria</article-title>
<source/>Crit Rev Biotechnol
          <year>2008</year>
<volume>28</volume>
<fpage>101</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">18568850</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heidrich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pieper</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Vital</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Uncovering the trimethylamine-producing bacteria of the human gut microbiota</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<fpage>54</fpage>
<pub-id pub-id-type="pmid">28506279</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rausch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lerchner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schiefner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Skerra</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Crystal structure of the omega-aminotransferase from <italic>Paracoccus denitrificans</italic> and its phylogenetic relationship with other class III aminotransferases that have biotechnological potential</article-title>
<source/>Proteins
          <year>2013</year>
<volume>81</volume>
<fpage>774</fpage>
<lpage>787</lpage>
<pub-id pub-id-type="pmid">23239223</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reger</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Zollinger</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Association between urinary phytoestrogens and C-reactive protein in the continuous national health and nutrition examination survey</article-title>
<source/>J Am Coll Nutr
          <year>2017</year>
<volume>36</volume>
<fpage>434</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="pmid">28628373</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichardt</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phylogenetic distribution of three pathways for propionate production within the human gut microbiota</article-title>
<source/>ISME J
          <year>2014</year>
<volume>8</volume>
<fpage>1323</fpage>
<lpage>1335</lpage>
<pub-id pub-id-type="pmid">24553467</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothschild</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">29489753</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuett</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylamine-<italic>N</italic>-oxide and heart failure with reduced versus preserved ejection fraction</article-title>
<source/>J Am Coll Cardiol
          <year>2017</year>
<volume>70</volume>
<fpage>3202</fpage>
<lpage>3204</lpage>
<pub-id pub-id-type="pmid">29268932</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuijt</surname>
<given-names>TJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia</article-title>
<source/>Gut
          <year>2016</year>
<volume>65</volume>
<fpage>575</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="pmid">26511795</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schumann</surname>
<given-names>RR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure and function of lipopolysaccharide binding protein</article-title>
<source/>Science
          <year>1990</year>
<volume>249</volume>
<fpage>1429</fpage>
<lpage>1431</lpage>
<pub-id pub-id-type="pmid">2402637</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seldin</surname>
<given-names>MM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylamine <italic>N</italic>-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-kappaB</article-title>
<source/>J Am Heart Assoc
          <year>2016</year>
<pub-id pub-id-type="pmid">26903003</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between microbiota-dependent metabolite trimethylamine-<italic>N</italic>-oxide and type 2 diabetes</article-title>
<source/>Am J Clin Nutr
          <year>2017</year>
<volume>106</volume>
<fpage>888</fpage>
<lpage>894</lpage>
<pub-id pub-id-type="pmid">28724646</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death</article-title>
<source/>Nature
          <year>2015</year>
<volume>526</volume>
<fpage>660</fpage>
<lpage>665</lpage>
<pub-id pub-id-type="pmid">26375003</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shih</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis</article-title>
<source/>J Lipid Res
          <year>2015</year>
<volume>56</volume>
<fpage>22</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">25378658</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoclet</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kleschyov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Andriambeloson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Diebolt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Andriantsitohaina</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Endothelial no release caused by red wine polyphenols</article-title>
<source/>J Physiol Pharmacol
          <year>1999</year>
<volume>50</volume>
<fpage>535</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="pmid">10639004</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylamine <italic>N</italic>-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome</article-title>
<source/>Biochem Biophys Res Commun
          <year>2016</year>
<volume>481</volume>
<fpage>63</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">27833015</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Heaney</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>Trimethylamine <italic>N</italic>-oxide and prognosis in acute heart failure</article-title>
<source/>Heart
          <year>2016</year>
<volume>102</volume>
<fpage>841</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="pmid">26869641</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Heaney</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>Trimethylamine <italic>N</italic>-oxide and risk stratification after acute myocardial infarction</article-title>
<source/>Clin Chem
          <year>2017</year>
<volume>63</volume>
<fpage>420</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="pmid">28062632</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>WH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk</article-title>
<source/>N Engl J Med
          <year>2013</year>
<volume>368</volume>
<fpage>1575</fpage>
<lpage>1584</lpage>
<pub-id pub-id-type="pmid">23614584</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>WH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota-dependent trimethylamine <italic>N</italic>-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease</article-title>
<source/>Circ Res
          <year>2015</year>
<volume>116</volume>
<fpage>448</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="pmid">25599331</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tazoe</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of short-chain fatty acid receptor GPR41 in the human colon</article-title>
<source/>Biomed Res
          <year>2009</year>
<volume>30</volume>
<fpage>149</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="pmid">19574715</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tolhurst</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</article-title>
<source/>Diabetes
          <year>2012</year>
<volume>61</volume>
<fpage>364</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">22190648</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trieu</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Uckun</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke</article-title>
<source/>Biochem Biophys Res Commun
          <year>1999</year>
<volume>258</volume>
<fpage>685</fpage>
<lpage>688</lpage>
<pub-id pub-id-type="pmid">10329446</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troseid</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota-dependent metabolite trimethylamine-<italic>N</italic>-oxide is associated with disease severity and survival of patients with chronic heart failure</article-title>
<source/>J Intern Med
          <year>2015</year>
<volume>277</volume>
<fpage>717</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">25382824</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuda</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Dietary anthocyanin-rich plants: biochemical basis and recent progress in health benefits studies</article-title>
<source/>Mol Nutr Food Res
          <year>2012</year>
<volume>56</volume>
<fpage>159</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">22102523</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tumur</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells</article-title>
<source/>Am J Nephrol
          <year>2009</year>
<volume>29</volume>
<fpage>551</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="pmid">19129694</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tumur</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Enomoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation</article-title>
<source/>Am J Nephrol
          <year>2010</year>
<volume>31</volume>
<fpage>435</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="pmid">20389059</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Trevino</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Fish odor syndrome: a case report of trimethylaminuria</article-title>
<source/>Dermatol Online J
          <year>2014</year>
<volume>20</volume>
<fpage>21260</fpage>
<pub-id pub-id-type="pmid">24456963</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vamanu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pelinescu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sarbu</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Comparative fingerprinting of the human microbiota in diabetes and cardiovascular disease</article-title>
<source/>J Med Food
          <year>2016</year>
<volume>19</volume>
<fpage>1188</fpage>
<lpage>1195</lpage>
<pub-id pub-id-type="pmid">27898282</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Schouw</surname>
<given-names>YT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women</article-title>
<source/>Circulation
          <year>2005</year>
<volume>111</volume>
<fpage>465</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="pmid">15687135</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanharanta</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation</article-title>
<source/>Atherosclerosis
          <year>2002</year>
<volume>160</volume>
<fpage>465</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="pmid">11849672</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanharanta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Voutilainen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rissanen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Adlercreutz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Salonen</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study</article-title>
<source/>Arch Intern Med
          <year>2003</year>
<volume>163</volume>
<fpage>1099</fpage>
<lpage>1104</lpage>
<pub-id pub-id-type="pmid">12742810</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vital</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Tiedje</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data</article-title>
<source/>MBio
          <year>2014</year>
<volume>5</volume>
<fpage>e00889</fpage>
<pub-id pub-id-type="pmid">24757212</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vonaesch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sansonetti</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Pathogens, microbiome and the host: emergence of the ecological Koch’s postulates</article-title>
<source/>FEMS Microbiol Rev
          <year>2018</year>
<pub-id pub-id-type="pmid">29325027</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahlstrom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sayin</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Marschall</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Backhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism</article-title>
<source/>Cell Metab
          <year>2016</year>
<volume>24</volume>
<fpage>41</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">27320064</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wampach</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>738</fpage>
<pub-id pub-id-type="pmid">28512451</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SI</given-names>
</name>
</person-group>
<article-title>Enhanced biosynthesis of dihydrodaidzein and dihydrogenistein by a newly isolated bovine rumen anaerobic bacterium</article-title>
<source/>J Biotechnol
          <year>2005</year>
<volume>115</volume>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">15639088</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>
<source/>Nature
          <year>2011</year>
<volume>472</volume>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">21475195</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Effects of phytoestrogen, genistein combined with calcium and vitamin D3 on preventing osteoporosis in ovariectomized mice</article-title>
<source/>Wei Sheng Yan Jiu
          <year>2011</year>
<volume>40</volume>
<fpage>587</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">22043708</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b</article-title>
<source/>Circ Res
          <year>2012</year>
<volume>111</volume>
<fpage>967</fpage>
<lpage>981</lpage>
<pub-id pub-id-type="pmid">22821931</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-<italic>N</italic>-oxide</article-title>
<source/>Eur Heart J
          <year>2014</year>
<volume>35</volume>
<fpage>904</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="pmid">24497336</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<fpage>1585</fpage>
<lpage>1595</lpage>
<pub-id pub-id-type="pmid">26687352</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methods to determine intestinal permeability and bacterial translocation during liver disease</article-title>
<source/>J Immunol Methods
          <year>2015</year>
<volume>421</volume>
<fpage>44</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">25595554</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Kuhnle</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Phytoestrogen consumption and association with breast, prostate and colorectal cancer in EPIC Norfolk</article-title>
<source/>Arch Biochem Biophys
          <year>2010</year>
<volume>501</volume>
<fpage>170</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">20494649</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>HA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition–Norfolk in relation to phytoestrogen intake derived from an improved database</article-title>
<source/>Am J Clin Nutr
          <year>2010</year>
<volume>91</volume>
<fpage>440</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="pmid">20007303</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warrier</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance</article-title>
<source/>Cell Rep
          <year>2015</year>
<pub-id pub-id-type="pmid">25600868</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webster</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>UA</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mieyal</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Identification of separate acyl-CoA: glycine and acyl-CoA: <sc>l</sc>-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man</article-title>
<source/>J Biol Chem
          <year>1976</year>
<volume>251</volume>
<fpage>3352</fpage>
<lpage>3358</lpage>
<pub-id pub-id-type="pmid">931988</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>IW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients—a prospective cohort study</article-title>
<source/>Nephrol Dial Transplant
          <year>2012</year>
<volume>27</volume>
<fpage>1169</fpage>
<lpage>1175</lpage>
<pub-id pub-id-type="pmid">21891772</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut dysbiosis is linked to hypertension</article-title>
<source/>Hypertension
          <year>2015</year>
<volume>65</volume>
<fpage>1331</fpage>
<lpage>1340</lpage>
<pub-id pub-id-type="pmid">25870193</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice</article-title>
<source/>Blood
          <year>2017</year>
<volume>129</volume>
<fpage>2667</fpage>
<lpage>2679</lpage>
<pub-id pub-id-type="pmid">28264799</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yisireyili</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats</article-title>
<source/>Life Sci
          <year>2013</year>
<volume>92</volume>
<fpage>1180</fpage>
<lpage>1185</lpage>
<pub-id pub-id-type="pmid">23702423</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokota</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Is bile acid a determinant of the gut microbiota on a high-fat diet?</article-title>
<source/>Gut Microbes
          <year>2012</year>
<volume>3</volume>
<fpage>455</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="pmid">22825495</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zdobnov</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>OrthoDB v9.1: cataloging evolutionary and functional annotations for animal, fungal, plant, archaeal, bacterial and viral orthologs</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>D744</fpage>
<lpage>D749</lpage>
<pub-id pub-id-type="pmid">27899580</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Experimental study on prevention and treatment of osteoporosis by phytoestrogen</article-title>
<source/>Zhongguo Zhong Xi Yi Jie He Za Zhi
          <year>2004</year>
<volume>24</volume>
<fpage>241</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">15074095</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>FM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease</article-title>
<source/>World J Gastroenterol
          <year>2013</year>
<volume>19</volume>
<fpage>7213</fpage>
<lpage>7216</lpage>
<pub-id pub-id-type="pmid">24222969</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases</article-title>
<source/>Andrology
          <year>2016</year>
<volume>4</volume>
<fpage>745</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="pmid">27260185</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/beta-catenin signaling</article-title>
<source/>Toxicol Lett
          <year>2018</year>
<volume>284</volume>
<fpage>29</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">29195902</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Selenoprotein P neutralizes lipopolysaccharide and participates in hepatic cell endoplasmic reticulum stress response</article-title>
<source/>FEBS Lett
          <year>2016</year>
<volume>590</volume>
<fpage>4519</fpage>
<lpage>4530</lpage>
<pub-id pub-id-type="pmid">27859223</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<fpage>1151</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="pmid">29590046</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2014</year>
<volume>111</volume>
<fpage>4268</fpage>
<lpage>4273</lpage>
<pub-id pub-id-type="pmid">24591617</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<fpage>111</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">26972052</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>WHW</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Gut microbe-generated trimethylamine <italic>N</italic>-oxide from dietary choline is prothrombotic in subjects</article-title>
<source/>Circulation
          <year>2017</year>
<volume>135</volume>
<fpage>1671</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="pmid">28438808</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>